Antiarrhythmic Activity of Diterpenoid Alkaloids
267
TABLE 2. Antiarrhythmic Activity of the Synthesized Compounds
on the Aconitine-Induced Arrhythmia Model in Rats
70 ml of a 5% KOH solution in methanol was boiled with re-
flux for 45 min. Upon cooling, methanol was evaporated and
the residue dissolved in 100 ml water and extracted with
chloroform. The extract was dried over sodium sulfate, after
which chloroform was distilled off. The residue was treated
with methanol to crystallize the target compound X (yield,
72%).
An analogous procedure was used for the synthesis of
1-O-benzoylsongorine (XIV) from dibenzoylsongorine
(XII).
Compound
LD50, mg/kg
ED50, mg/kg AAI = ED50/LD50
I
88.0
101.0
82.0
10.0
15.0
80.0
28.0
7.3
8.8
6.7
II
III
IV
V
10.0
25.8
19.0
10.0
6.7
725.0
142.0
120.0
100.0
175.0
30.0
VI
12.0
15.0
20.0
0.24
18.0
15.0
VIII
OR2
IX
8.8
OH
X
133.3
7.3
OR1
CH2
12
OH
N
CH2
16
15
XI
131.0
150.0
41.0
14
XIII
10.0
107.9
1
N
4
10
8
OR3
XIV
0.38
OH
6
Novocainamide
Quinidine
Lidocaine
110.0
66.9
40.0
20.0
10.0
2.75
CH3
CH3
3.3
3.9
III
OH
39.0
I: R1 = R2 = R3 = H;
II: R1 = R3 = H, R2 = Ac;
VII: R1 = R2 = R3 = Ac;
VIII: R1 = Ac, R2 = R3 = H;
IX: R1 = R2 = R3 = Bz;
X: R1 = Bz, R2 = R3 = H.
OH
CH2
O
It was established that most of the studied compounds
produce a more or less pronounced antiarrhythmic effect (Ta-
ble 2). The maximum activity was observed for 1-O-benzo-
ylnapelline (X), the effect of which markedly exceeded that
of the initial napelline and the reference class I antiarrhyth-
mic drugs novocainamide, quinidine, and lidocaine.
N
OH
CH3
IV
O
O
CH3
OR1
N
CH2
OH
N
REFERENCES
1. F. N. Dzhakhangirov, Abstracts of Papers. The All-Union con-
gress of Pharmacists “Physiologically Active Substances in
Medicine” [in Russian], Yerevan (1983), p. 103.
2. Ì. N. Berai and J. M. Jacyno, in: Alkaloids: Chemical and Bio-
logical Perspectives, S. W. Pelletier (ed.), Wiley, New York
(1984), Vol., 1 Ch. 4., p. 153.
3. F. N. Dzhakhangirov, Abstracts of Papers. Int. Conf. “Medici-
nal Raw Materials and Phytopreparations for Medicine and Ag-
riculture,” Karaganda (1999), p. 130.
OR2
OH
CH3
CH3
VI
V: R1 = R2 = H;
XI: R1 = R2 =Ac;
XII: R2 = R2 = Bz;
XIII: R1 = Ac, R2 = H;
XIV: R1 = Bz, R2 = H.
4. F. N. Dzhakhangirov, F. Sokolov, and A. N. Verkhratskii,
Allapinine: A New Antiarrhythmic Preparation [in Russian],
Fan, Tashkent (1993).
EXPERIMENTAL PHARMACOLOGICAL PART
5. Sh. Sh. Sagdullaev, A. Z. Sadikov, F. N. Dzhakhangirov, and
T. T. Shakirov, Khim. Prir. Soedin. (Spec. Issue), 134 – 137
(1999).
6. M. N. Sultankhodzhaev and M. S. Yunusov, Khim. Prir.
Soedin., No. 3, 381 – 383 (1975).
7. M. N. Sultankhodzhaev, M. S. Yunusov, and S. Yu. Yunusov,
Khim. Prir. Soedin., No. 4, 479 – 482 (1978).
8. S. Yu. Yunusov, Izv. Akad. Nauk UzSSR, 3, 31 (1947).
9. M. N. Sultankhodzhaev, M. S. Yunusov, and S. Yu. Yunusov,
Khim. Prir. Soedin., No. 2, 199 – 205 (1973).
10. M. N. Sultankhodzhaev and M. S. Yunusov, Khim. Prir.
Soedin., No. 3, 386 – 388 (1987).
11. M. N. Sultankhodzhaev, L. V. Beshitaishvili, M. S. Yunusov,
and S. Yu. Yunusov, Khim. Prir. Soedin., No. 6, 826 – 829
(1979).
The acute toxicity was determined by intravenous injec-
tions in a group of 340 white mice weighing 18 – 22 g. The
antiarrhythmic activity was studied on an aconitine-induced
arrhythmia model in a group of rats weighing 200 – 250 g.
The animals were narcotized by ethaminal sodium
(40 mg/kg, i.p.), aconitine was intraperitoneally injected in a
dose of 12 mg/kg, and EEG were measured in a second stan-
dard lead. The synthesized compounds were intravenously
injected in increasing (3 – 4 steps) doses 3 – 5 min before
aconitine injections. The effect of each dose was studied in a
group of 5 – 6 animals.
The LD50 and ED50 were calculated by the Litch-
field – Wilcoxon method. The therapeutic breadth was evalu-
ated by the antiarrhythmic index (AAI) calculated as the ra-
tio of lethal and effective doses (LD50/ED50).
12. M. N. Sultankhodzhaev and M. S. Yunusov, Khim. Prir.
Soedin., No. 6, 917 – 918 (1987).